From Pericytes to the Heart: A Microvascular Link in Systemic Sclerosis
Abstract
Agarwal, Bankar, and de Jesus Perez provide an insightful overview of lung pericytes as dynamic regulators of microvascular homeostasis, angiogenesis, tissue repair, inflammation, and vascular remodeling (Agarwal et al. 2026). Their synthesis of PDGF-BB/PDGFRβ, TGF-β, VEGF, angiopoietin/Tie2, Notch, Wnt, and sphingosine- 1-phosphate signaling pathways highlights pericytes as a potential cellular interface between endothelial injury, vascular dysfunction, and maladaptive re-modeling (Agarwal et al. 2026). This framework may be particularly relevant to systemic autoimmune diseases, in which pulmonary vascular disease and myocardial involvement frequently coexist within a broader microvascular phenotype. The emerging role of microvascular dysfunction in systemic sclerosis (SSc) cardiac disease further supports this concept. Coppi, Pagnoni, et al. (2026) recently emphasized mitochondrial dysfunction and molecular signaling as potential determinants of myocardial injury in SSc. In this setting, recurrent microvascular ischemia, immune-mediated myocardial inflammation, and progressive fibrosis appear to represent interconnected rather than independent mechanisms of primary cardiac involvement (Coppi, Pagnoni, et al. 2026; Soo et al. 2026). Importantly, peripheral microvascular dysfunction in SSc-associated pulmonary